Trusted Resources: Community Center
A Guide to Understanding MPS VI
MPS VI (Maroteaux-Lamy syndrome) is caused by a recessive gene. There is a one in four chance with every pregnancy that the child will inherit the defective gene from each carrier parent and will be affected with the disease. There is a two in three chance that unaffected brothers and sisters of MPS VI children will be carriers.
MPS VI is a mucopolysaccharide disease known as Maroteaux-Lamy Syndrome. It takes its name from two French Doctors, Dr. Maroteaux and Dr. Lamy, who first described the condition in 1963. MPS VI has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS VI.
BookmarkRelated Content
-
A Guide to Understanding MPS IIIMPS III is a mucopolysaccharide disease ...
-
Believe in G Golf TournamentGianna, was diagnosed with Sanfilippo Sy...
-
Disease Burden, Management Patterns and Multidisciplinary Clinical Approaches for Patients With MPS IVA and VI in Se...There is a paucity of real-world epidemi...
-
H4B Boston’s Living Rooms of RareIn celebration of Rare Disease Day, H4B ...
-
Fall Family FundraisingLast year, we initiated our annual Fall ...
-
Oliver’s Tomorrow Night at Columbus Blue JacketsThe NHL’s Columbus Blue Jackets are de...
-
Clinical and Event-Based Outcomes of Patients With Mucopolysaccharidosis VI Receiving Enzyme Replacement Therapy in ...The objective of this study was to descr...
